6 Best Heart Rate Monitors for Arrhythmia 2026

Sleek, life-saving convenience packed into a wallet-sized marvel — the KardiaMobile Card redefines what it means to monitor heart health on the move. With FDA-cleared accuracy, this ultra-thin device delivers medical-grade EKGs in just 30 seconds, detecting key arrhythmias like AFib, bradycardia, and tachycardia — critical for anyone managing irregular heartbeats. Its credit-card form factor isn’t just a gimmick; it’s a game-changer for compliance, ensuring users always have access to rapid cardiac insights when palpitations strike, whether at work, travel, or rest.

In real-world testing, the Bluetooth-enabled device pairs seamlessly with smartphones, requiring only finger contact on the sensors to generate a readable EKG. The free Kardia app stores and organizes results, making it easy to track patterns or share reports with doctors. While it only captures a single-lead ECG, which limits anatomical perspective compared to multi-lead systems, it excels in spot-check scenarios where speed and portability are paramount. However, users relying on pacemakers or ICDs should avoid this device, as it’s not validated for those conditions.

When stacked against the EMAY models, the KardiaMobile Card stands out for trusted clinical validation and being the #1 cardiologist-recommended brand, offering unmatched credibility. It’s ideal for individuals seeking on-demand arrhythmia screening without recurring costs, especially those with intermittent symptoms who need reliable, quick checks. While the EMAY 6L offers more leads, this Kardia model delivers superior brand trust, ease of use, and true pocketability, making it a smarter pick for users prioritizing proven reliability over technical depth.

The EMAY Portable ECG Monitor delivers no-frills functionality with solid performance for budget-conscious users seeking basic at-home heart rhythm tracking. This OTC-approved device records Lead I ECG waveforms and displays real-time heart rate, offering a practical tool for spotting irregularities like AFib during symptomatic episodes. Its dual connectivity — Bluetooth to smartphones and USB to PCs — broadens usability across platforms, appealing to users who prefer desktop analysis or telehealth reporting. The rechargeable battery eliminates the need for constant replacements, enhancing long-term value.

During hands-on use, the device proved responsive and stable when paired with both Android and iOS devices, though the companion app feels less polished than Kardia’s. It reliably captures short-duration ECG clips, useful for documenting transient arrhythmias, but lacks automated rhythm interpretation beyond basic heart rate display. While it supports storage and review via software, the analysis tools require manual input, making it less accessible for non-technical users. Like all single-lead monitors, it provides limited diagnostic context compared to clinical-grade systems.

Compared to the KardiaMobile 1-Lead, this EMAY model offers similar lead capability but without FDA clearance or cardiologist-backed validation, placing it at a disadvantage for users needing medically trusted results. It’s best suited for individuals wanting an affordable entry point into personal ECG monitoring, perhaps for preliminary tracking before consulting a physician. While it matches the KardiaMobile in portability and ease of charging, it falls short in result clarity and medical credibility, making it a functional but less authoritative option.

For users demanding deeper cardiac insight without monthly fees, the EMAY 6L Portable ECG Monitor steps up as a rare budget-friendly six-lead solution. Unlike most consumer devices limited to single-lead readings, this unit captures six-channel ECG data, offering a much richer view of heart activity — crucial for identifying complex arrhythmias that may be missed with simpler tools. The no-subscription model is a major win, granting full access to recordings, storage, and software features straight out of the box. Its rechargeable design ensures long-term use without battery replacements.

In practice, the device performs well when used correctly, though achieving consistent contact across all channels requires careful finger placement and stillness during recording. The companion app and PC software allow for time-stamped sampling, case reviews, and measurements, making it a solid choice for users who want to analyze trends over time or share detailed reports with doctors. However, while it records six leads, it doesn’t provide automated arrhythmia detection like Kardia’s AI-powered system, leaving interpretation largely to the user or physician. It also shares the same limitation: not recommended for pacemaker users.

Next to the KardiaMobile 6L Max, the EMAY 6L offers comparable lead coverage but lacks FDA clearance and real-time AI analysis, reducing its clinical authority. Still, for tech-savvy individuals or caregivers wanting detailed ECGs at a fraction of the cost, it’s an excellent value proposition. Where the Kardia 6L Max excels in automated insights and cardiologist reviews, this EMAY model wins on transparency and ownership of data. It’s the go-to for those who prioritize technical depth and no hidden fees over guided diagnostics.

Ultra-portable and instantly reliable, the KardiaMobile 1-Lead EKG Monitor is the gold standard in pocket-sized heart rhythm screening, built for those who need fast, FDA-cleared answers during heart flutters or fatigue. Weighing less than an ounce, it slips into a jacket pocket or purse, ready to deliver a medical-grade EKG in 30 seconds — no Bluetooth, Wi-Fi, or computer required. The simple two-sensor design lets users place thumbs on top to capture a Lead I reading, with results displayed clearly in the app as normal, AFib, tachycardia, or bradycardia.

Real-world testing confirms its consistency and speed, especially valuable for people with paroxysmal arrhythmias that come and go unpredictably. The free Kardia app stores unlimited EKGs, allows tagging (e.g., ‘after coffee’ or ‘during chest pain’), and supports direct email sharing with doctors — a huge advantage over devices without integrated reporting. Powered by a long-lasting CR2016 battery (up to two years), it minimizes maintenance. However, like all single-lead devices, it can’t detect certain arrhythmias that require multiple angles of heart activity.

Against the EMAY portable models, this Kardia version stands tall with FDA clearance, superior software, and global cardiologist endorsement. While the EMAY devices offer PC connectivity, they lack the automated detection and trusted clinical backing that make Kardia a go-to in telehealth. It’s perfect for users wanting quick, credible arrhythmia checks without complexity or subscriptions. Compared to the 6L Max, it delivers fewer leads and less diagnostic detail, but wins on simplicity, battery life, and zero connectivity hassles.

Revolutionary in scope and execution, the Biotricity Bioheart is the only device in this lineup that delivers true 24/7 continuous heart monitoring — a game-changing leap from spot-check EKGs for those managing chronic or elusive arrhythmias. Using a medical-grade chest strap, it captures every heartbeat across days or weeks, offering uninterrupted rhythm tracking that can uncover patterns invisible to brief snapshots. AI-driven insights flag anomalies in real time, while the app generates shareable PDF reports — ideal for proactive discussions with cardiologists.

Field testing revealed exceptional comfort and reliability, with the breathable, washable fabric causing no irritation even during sleep or workouts. The 48-hour battery life means fewer charges, and Bluetooth sync keeps data flowing seamlessly to smartphones. Unlike single-lead devices that miss infrequent events, the Bioheart captures every beat, making it invaluable for diagnosing conditions like nocturnal AFib or exercise-induced tachycardia. That said, it requires consistent skin contact and isn’t suitable for those who dislike wearing sensors around the clock.

Pitted against Kardia’s spot-check models, the Bioheart trades immediate convenience for comprehensive coverage — it’s not for quick checks, but for deep, longitudinal analysis. Where Kardia excels in on-demand clarity, Bioheart dominates in continuous detection. It’s the best choice for patients with undiagnosed or recurring symptoms needing extended monitoring without a prescription. While pricier in subscription model, its award-winning tech and clinical rigor offer unmatched depth, positioning it as the most advanced wearable ECG system for serious heart health management.

The definitive all-in-one solution for at-home arrhythmia detection, the KardiaMobile 6L Max raises the bar with six-lead EKGs in 30 seconds, delivering six times more cardiac data than standard single-lead devices. This isn’t just incremental improvement — it’s a diagnostic upgrade that allows detection of nuanced arrhythmias like PVCs, SVE, and wide QRS complexes, making it invaluable for users with complex or evolving heart conditions. Backed by FDA clearance and KardiaCare, it combines hardware precision with AI-powered analysis and board-certified cardiologist reviews — a rare level of clinical integration in consumer devices.

In daily use, the device feels intuitive: users place fingers on top electrodes and one leg on the bottom sensor to complete the circuit, generating a detailed EKG almost instantly. The KardiaCare subscription, included for one year, unlocks automated arrhythmia tagging, trend reports, and four free cardiologist reviews annually — a massive value for ongoing heart care. Data can be auto-emailed to doctors, and telehealth appointments are available. However, after the first year, renewal fees apply, which may deter budget-focused users. Also, while highly portable, it requires consistent posture and contact for clean readings.

Compared to the EMAY 6L, the 6L Max is in a different league — it offers FDA-cleared AI analysis, clinical support, and physician integration, whereas the EMAY relies on user interpretation. Against the base KardiaMobile 1-Lead, it provides far greater diagnostic depth and automated insights. It’s ideal for users who want hospital-grade data at home, especially those managing diagnosed arrhythmias or under cardiology care. While the Bioheart wins on duration of monitoring, the 6L Max triumphs in diagnostic precision and ease of use, making it the best overall heart rate monitor for arrhythmia.